Brian Evanko will assume CEO duties July 1, 2026 after overseeing Cigna Healthcare and Evernorth, signaling continuity in ...

Testosterone can potentiate S. aureus quorum sensing independent of auto-inducing peptides, increasing toxin release and host-cell damage, whereas progesterone and estrogen do not show the same effect ...

A custom NGS panel covering 27 IARC carcinogenic HPV genotypes enabled detection of ccfHPV DNA across treatment strata and ...

Zahra Mahmoudjafari explains how cell and gene therapy programs succeed with strong infrastructure, pharmacy leadership, ...

The May 29, 2026 PDUFA targets pediatric approval of Afrezza for type 1 or type 2 diabetes, leveraging INHALE-1 outcomes versus rapid-acting analogs plus basal insulin. INHALE-1 was open-label and ...

The results show that those with low vitamin D levels had a significantly higher risk of hospitalization related to respiratory tract infection compared with those whose 25 (OH)D levels were 75 nmol/L ...

A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma ...

Cost-effectiveness is highly price-sensitive; lower U.S. prices, particularly approaching European levels, shift semaglutide toward favorable value rather than a binary go/no-go determination. Patient ...

Risant’s CEO Jaewon Ryu discusses some of the early success of bringing a set of Kaiser Permanente’s value-based care ...

In the first segment of a video interview with MHE, the CEO of Risant Health discusses the role of scale in following ...

In an hour and 48-minute speech that set the record for length for the State of the Union address, President Donald Trump spent less than five minutes on healthcare issues.

Predictable reimbursement is a primary operational determinant of biosimilar longevity in practices, frequently outweighing ...